Source of donor stem cells impacts incidence of bleeding and platelet and RBC transfusion requirements during stem cell transplantation (SCT): results of the phase III sprint trial of intercept pathogen inactivated platelets

  • Vesole D
  • Stadtmauer E
  • Goodnough L
  • et al.
N/ACitations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Vesole, D., Stadtmauer, E., Goodnough, L. T., Coutre, S., Howard, F., Lin, J.-S., & Conlan, M. G. (2004). Source of donor stem cells impacts incidence of bleeding and platelet and RBC transfusion requirements during stem cell transplantation (SCT): results of the phase III sprint trial of intercept pathogen inactivated platelets. Biology of Blood and Marrow Transplantation, 10, 85. https://doi.org/10.1016/j.bbmt.2003.12.166

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free